当前位置：
X-MOL 学术
›
Lancet Diabetes Endocrinol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Issues with European guidelines for phenylketonuria – Authors' reply
The Lancet Diabetes & Endocrinology ( IF 44.0 ) Pub Date : 2017-09-01 , DOI: 10.1016/s2213-8587(17)30202-4 Francjan J van Spronsen , Annemiek M J van Wegberg , Kirsten Ahring , Amaya Bélanger-Quintana , Nenad Blau , Annet M Bosch , Alberto Burlina , Jaime Campistol , Francois Feillet , Maria Giżewska , Stephan C Huijbregts , Shauna Kearney , Vincenzo Leuzzi , Francois Maillot , Ania C Muntau , Fritz K Trefz , Margreet van Rijn , Anita MacDonald
The Lancet Diabetes & Endocrinology ( IF 44.0 ) Pub Date : 2017-09-01 , DOI: 10.1016/s2213-8587(17)30202-4 Francjan J van Spronsen , Annemiek M J van Wegberg , Kirsten Ahring , Amaya Bélanger-Quintana , Nenad Blau , Annet M Bosch , Alberto Burlina , Jaime Campistol , Francois Feillet , Maria Giżewska , Stephan C Huijbregts , Shauna Kearney , Vincenzo Leuzzi , Francois Maillot , Ania C Muntau , Fritz K Trefz , Margreet van Rijn , Anita MacDonald
Peter Burgard and colleagues argue that two key statements from our key European guidelines on phenylketonuria1 are too contentious.
中文翻译：
欧洲苯丙酮尿症指南的问题–作者的回复
彼得·伯加德（Peter Burgard）和他的同事认为，我们关于苯丙酮尿症1的重要欧洲指南中的两个主要说法太有争议了。
更新日期：2017-08-23
中文翻译：
欧洲苯丙酮尿症指南的问题–作者的回复
彼得·伯加德（Peter Burgard）和他的同事认为，我们关于苯丙酮尿症1的重要欧洲指南中的两个主要说法太有争议了。
京公网安备 11010802027423号